Procept BioRobotics Total Liabilities

Procept BioRobotics (PRCT) currently reports a total liabilities of $140M as of September 2026. That compares with $130M in the prior-year period — up 10.4% year over year. Use the charts on this page to explore Procept BioRobotics's total liabilities history and peer comparisons.

Procept BioRobotics's total liabilities increased from $130M to $140M — a 10.4% year-over-year increase (period ending September 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Procept BioRobotics reported $140M in total liabilities as of September 2026. That compares with $130M in the prior-year period — up 10.4% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total liabilities of $140M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Procept BioRobotics, and consider following PRCT for alerts when major investors trade the stock.

Procept BioRobotics is classified in the Healthcare sector. On total liabilities, it currently shows $140M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing PRCT with unrelated industries.